JP Morgan Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Negative 82.9%

Neg 82.9% Neu 0% Pos 0%

JP Morgan analyst Robbie Marcus maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $80 to $65.